NO20031409L - Ionestyrkeuavhengig farmasoytiske preparat med langvarig frigivelse - Google Patents

Ionestyrkeuavhengig farmasoytiske preparat med langvarig frigivelse

Info

Publication number: NO20031409L
Authority: NO; Norway
Prior art keywords: pharmaceutical preparations; release pharmaceutical; ion strength; strength independent; independent long
Prior art date: 2000-09-29

Application number

NO20031409A

Other languages

English (en)

Other versions

NO20031409D0 (no

Inventor

Henricus R M Gorissen

Henderik W Frijlink

Original Assignee

Solvay Pharm Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-29

Filing date

2003-03-27

Publication date

2003-03-27

2003-03-27 Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv

2003-03-27 Publication of NO20031409D0 publication Critical patent/NO20031409D0/no

2003-03-27 Publication of NO20031409L publication Critical patent/NO20031409L/no

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1
239000013543 active substance Substances 0.000 abstract 3
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000012530 fluid Substances 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Nutrition Science (AREA)
Virology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Physiology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Addiction (AREA)

NO20031409A 2000-09-29 2003-03-27 Ionestyrkeuavhengig farmasoytiske preparat med langvarig frigivelse NO20031409L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
NL1016295		2000-09-29
EP00203381		2000-09-29
PCT/EP2001/011285 WO2002026214A1 (en)	2000-09-29	2001-09-28	Ion-strength independent sustained release pharmaceutical formulation

Publications (2)

Publication Number	Publication Date
NO20031409D0 NO20031409D0 (no)	2003-03-27
NO20031409L true NO20031409L (no)	2003-03-27

Family

ID=26072736

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031409A NO20031409L (no)	2000-09-29	2003-03-27	Ionestyrkeuavhengig farmasoytiske preparat med langvarig frigivelse

Country Status (25)

Country	Link
US (1)	US8034379B2 (no)
EP (1)	EP1345595B1 (no)
JP (1)	JP5049450B2 (no)
KR (1)	KR100833469B1 (no)
CN (1)	CN1466451B (no)
AT (1)	ATE361060T1 (no)
AU (2)	AU2002223572B2 (no)
BR (1)	BR0114272A (no)
CA (1)	CA2426666A1 (no)
CZ (1)	CZ299411B6 (no)
DE (1)	DE60128263T2 (no)
DK (1)	DK1345595T3 (no)
DZ (1)	DZ3473A1 (no)
ES (1)	ES2284709T3 (no)
HU (1)	HUP0301177A3 (no)
IL (2)	IL154731A0 (no)
MX (1)	MXPA03002769A (no)
NO (1)	NO20031409L (no)
NZ (1)	NZ524641A (no)
PL (1)	PL203217B1 (no)
PT (1)	PT1345595E (no)
RU (1)	RU2285519C2 (no)
SI (1)	SI1345595T1 (no)
SK (1)	SK287066B6 (no)
WO (1)	WO2002026214A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070099931A1 (en) *	2004-03-19	2007-05-03	Wyeth	Pharmaceutical dosage forms and compositions
NZ551356A (en)	2004-05-11	2009-09-25	Emotional Brain Bv	Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
US20060003003A1 (en) *	2004-06-28	2006-01-05	Bakker Johan A	Oral sustained release formulation of tedisamil with gastric retention properties
AR049936A1 (es) *	2004-06-28	2006-09-13	Solvay Pharm Bv	Formulacion oral de liberacion sostenida de tedisamil con propiedades de retencion gastrica
KR20070028598A (ko) *	2004-06-28	2007-03-12	솔베이 파마슈티칼스 비. 브이	위 체류 성질을 갖는 테디사밀의 경구용 서방성 제제
JP2006143598A (ja) *	2004-11-16	2006-06-08	Nichi-Iko Pharmaceutical Co Ltd	経時的な変色を抑制した医薬組成物
WO2007030589A2 (en) *	2005-09-09	2007-03-15	Wyeth	Pharmaceutical dosage forms and compositions comprising lecoztan
EP1790343A1 (en)	2005-11-11	2007-05-30	Emotional Brain B.V.	Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
US8669258B2 (en) *	2006-10-30	2014-03-11	The Board Of Regents Of The University Of Texas System	Treatment for gastroparesis using sepiapterin
WO2008054693A2 (en) *	2006-10-30	2008-05-08	The Board Of Regents Of The University Of Texas System	Uses of tetrahydrobiopterin and derivatives thereof
EP1925307A1 (en) *	2006-11-03	2008-05-28	Emotional Brain B.V.	Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
US7965077B2 (en) *	2008-05-08	2011-06-21	Everspin Technologies, Inc.	Two-axis magnetic field sensor with multiple pinning directions
BRPI1007945C8 (pt)	2009-02-13	2021-05-25	Romark Laboratories Lc	formulação farmacêutica de liberação controlada de nitazoxanida, tizoxanida ou uma combinação dos mesmos, e, comprimido de bicamada para administração oral
WO2013157833A1 (ko) *	2012-04-18	2013-10-24	서울대학교산학협력단	베타-차단제를 유효성분으로 포함하는 비만, 비만으로 인한 대사성 질환 및 골감소증 예방, 개선 또는 치료용 조성물
KR102116495B1 (ko) *	2013-08-28	2020-06-03	삼성디스플레이 주식회사	축합환 화합물을 포함하는 유기 전계 발광 소자
TW201618783A (zh)	2014-08-07	2016-06-01	艾森塔製藥公司	以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
CN104352471A (zh) *	2014-11-21	2015-02-18	哈尔滨圣吉药业股份有限公司	一种马来酸氟伏沙明缓释片及其制备方法
CA3067031A1 (en)	2017-06-21	2018-12-27	Minerva Neurosciences, Inc.	Gastro-resistant controlled release oral dosage forms
TWI841545B (zh) *	2018-12-12	2024-05-11	日商田邊三菱製藥股份有限公司	耐胃性控制釋放經口劑型
US12016851B2 (en) *	2022-04-11	2024-06-25	Chiesi Farmaceutici S.P.A.	Modified release pharmaceutical formulations comprising deferiprone

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4389393A (en) *	1982-03-26	1983-06-21	Forest Laboratories, Inc.	Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
FR2588188B1 (fr)	1985-10-04	1988-01-08	Delalande Sa	Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation
US4786503A (en)	1987-04-06	1988-11-22	Alza Corporation	Dosage form comprising parallel lamine
US5387419A (en) *	1988-03-31	1995-02-07	The University Of Michigan	System for controlled release of antiarrhythmic agents
US5009895A (en) *	1990-02-02	1991-04-23	Merck & Co., Inc.	Sustained release with high and low viscosity HPMC
DE4139763A1 (de) *	1991-12-03	1993-06-09	Kali-Chemie Pharma Gmbh, 3000 Hannover, De	Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4329794C2 (de) *	1993-09-03	1997-09-18	Gruenenthal Gmbh	Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
ZA959221B (en)	1994-11-02	1997-04-30	Janssen Pharmaceutica Nv	Cisapride extended release
CN1162263A (zh) *	1994-11-02	1997-10-15	詹森药业有限公司	西沙必利的缓释口服组合物
WO1997004752A1 (en) *	1995-07-26	1997-02-13	Duramed Pharmaceuticals, Inc.	Pharmaceutical compositions of conjugated estrogens and methods for their use
CA2216215A1 (en) *	1997-04-05	1998-10-05	Isa Odidi	Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
ES2248908T7 (es) *	1997-06-06	2014-11-24	Depomed, Inc.	Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
US5948440A (en)	1997-12-17	1999-09-07	Ranbaxy Laboratories Limited	Modified release matrix formulation of cefaclor and cephalexin
US6099859A (en) *	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
EP1086063A4 (en) *	1998-06-08	2001-03-28	Advanced Medicine Inc	Novel potassium channel drugs and their uses
CN1406126A (zh) *	1998-10-01	2003-03-26	诺瓦提斯公司	新型缓释口服制剂
CO5140079A1 (es) *	1998-10-14	2002-03-22	Novartis Ag	Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
DE60117857D1 (de)	2000-12-27	2006-05-04	Genzyme Corp	Kontrollierte freisetzung von anti-arrhythmica aus einem biodegradierbaren hydrogel für die lokale anwendung am herzen

2001
- 2001-09-28 ES ES01985673T patent/ES2284709T3/es not_active Expired - Lifetime
- 2001-09-28 MX MXPA03002769A patent/MXPA03002769A/es active IP Right Grant
- 2001-09-28 CN CN01816515XA patent/CN1466451B/zh not_active Expired - Fee Related
- 2001-09-28 DE DE60128263T patent/DE60128263T2/de not_active Expired - Lifetime
- 2001-09-28 US US10/381,714 patent/US8034379B2/en not_active Expired - Fee Related
- 2001-09-28 CZ CZ20030898A patent/CZ299411B6/cs not_active IP Right Cessation
- 2001-09-28 DZ DZ013473A patent/DZ3473A1/fr active
- 2001-09-28 BR BR0114272-0A patent/BR0114272A/pt not_active Application Discontinuation
- 2001-09-28 DK DK01985673T patent/DK1345595T3/da active
- 2001-09-28 CA CA002426666A patent/CA2426666A1/en not_active Withdrawn
- 2001-09-28 SK SK355-2003A patent/SK287066B6/sk not_active IP Right Cessation
- 2001-09-28 HU HU0301177A patent/HUP0301177A3/hu unknown
- 2001-09-28 JP JP2002530044A patent/JP5049450B2/ja not_active Expired - Fee Related
- 2001-09-28 AU AU2002223572A patent/AU2002223572B2/en not_active Ceased
- 2001-09-28 EP EP01985673A patent/EP1345595B1/en not_active Expired - Lifetime
- 2001-09-28 PT PT01985673T patent/PT1345595E/pt unknown
- 2001-09-28 WO PCT/EP2001/011285 patent/WO2002026214A1/en not_active Ceased
- 2001-09-28 PL PL360670A patent/PL203217B1/pl unknown
- 2001-09-28 AT AT01985673T patent/ATE361060T1/de active
- 2001-09-28 IL IL15473101A patent/IL154731A0/xx active IP Right Grant
- 2001-09-28 KR KR1020037004552A patent/KR100833469B1/ko not_active Expired - Fee Related
- 2001-09-28 AU AU2357202A patent/AU2357202A/xx active Pending
- 2001-09-28 RU RU2003112459/15A patent/RU2285519C2/ru not_active IP Right Cessation
- 2001-09-28 SI SI200130732T patent/SI1345595T1/sl unknown
- 2001-09-28 NZ NZ524641A patent/NZ524641A/en not_active IP Right Cessation
2003
- 2003-03-04 IL IL154731A patent/IL154731A/en not_active IP Right Cessation
- 2003-03-27 NO NO20031409A patent/NO20031409L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE60128263D1 (de)	2007-06-14
BR0114272A (pt)	2003-08-26
PL203217B1 (pl)	2009-09-30
SI1345595T1 (sl)	2007-08-31
HUP0301177A2 (hu)	2003-10-28
EP1345595B1 (en)	2007-05-02
AU2357202A (en)	2002-04-08
CZ2003898A3 (cs)	2003-06-18
SK3552003A3 (en)	2003-10-07
JP5049450B2 (ja)	2012-10-17
CN1466451B (zh)	2010-05-12
RU2285519C2 (ru)	2006-10-20
CA2426666A1 (en)	2002-04-04
DK1345595T3 (da)	2007-09-10
CZ299411B6 (cs)	2008-07-16
CN1466451A (zh)	2004-01-07
PL360670A1 (en)	2004-09-20
US20040013727A1 (en)	2004-01-22
JP2004509915A (ja)	2004-04-02
HUP0301177A3 (en)	2006-07-28
KR100833469B1 (ko)	2008-05-29
NO20031409D0 (no)	2003-03-27
HK1060691A1 (en)	2004-08-20
NZ524641A (en)	2004-09-24
PT1345595E (pt)	2007-08-13
EP1345595A1 (en)	2003-09-24
WO2002026214A1 (en)	2002-04-04
DE60128263T2 (de)	2008-01-10
US8034379B2 (en)	2011-10-11
KR20030036861A (ko)	2003-05-09
ATE361060T1 (de)	2007-05-15
IL154731A (en)	2008-11-26
IL154731A0 (en)	2003-10-31
AU2002223572B2 (en)	2005-09-08
ES2284709T3 (es)	2007-11-16
MXPA03002769A (es)	2003-07-28
SK287066B6 (sk)	2009-11-05
DZ3473A1 (fr)	2002-04-04

Legal Events

Date	Code	Title	Description
2013-02-11	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20031409D0 (no)	2003-03-27	Ionestyrkeuavhengig farmasöytiske preparat med langvarig frigivelse
AR045956A1 (es)	2005-11-16	Multiparticulas de pantoprazol y formulacion que las contiene
TR200200562T2 (tr)	2002-05-21	Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
BR0107565A (pt)	2003-02-11	Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
SE0300831D0 (sv)	2003-03-26	New formulations and use therof
CY1106072T1 (el)	2011-06-08	Φαρμακευτικη μορφη δοσης παρατεταμενης αποδεσμευσης απο του στοματος
ECSP045102A (es)	2004-06-28	Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
ATE302616T1 (de)	2005-09-15	Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
BG108516A (en)	2004-12-30	Pharmaceutical formulation
ECSP083351A (es)	2008-08-29	Composiciones farmacéuticas
BR0314797A (pt)	2005-07-26	Derivados da pirimidineamida e o uso dos mesmos
DE60233898D1 (de)	2009-11-12	Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin-plasmaspiegeln
DE50005529D1 (de)	2004-04-08	Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
ATE470443T1 (de)	2010-06-15	Indol-1-yl-essigsäurederivate
ATE262893T1 (de)	2004-04-15	Darreichungsformen zur behandlung von oralen mykosen
NO20101070L (no)	2001-02-05	Fremgangsmate til dosering av et medikament, samt doseringsform
WO2001013898A3 (en)	2001-05-25	Pharmaceutical formulations with different release times
ATE464878T1 (de)	2010-05-15	Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
AU2001274374A1 (en)	2002-01-02	Matrix protein compositions for dentin regeneration
DK1343472T3 (da)	2006-09-25	Thixotropisk næsespray
HUP0002346A1 (hu)	2001-05-28	Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
ATE226065T1 (de)	2002-11-15	Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
NO323466B1 (no)	2007-05-21	Nye kinolinyl-piperidin-4-yliden-metyl-benzamidderivater, fremgangsmate til fremstilling derav, anvendelse derav i medikamenter til behandling av smerte, samt farmasoytisk sammensetning som innbefatter slike derivater
SE0001916D0 (sv)	2000-05-23	Novel formulation
CO2025001080A2 (es)	2025-02-13	Una formulación líquida oral farmacéutica estable de un agente antiespasmódico